830 related articles for article (PubMed ID: 24693200)
1. Autologous Immune Enhancement Therapy for Cancer - Our experience since 2004.
Terunuma H
J Stem Cells Regen Med; 2012; 8(3):205-6. PubMed ID: 24693200
[TBL] [Abstract][Full Text] [Related]
2. Autologous Immune Enhancement Therapy for cancer using NK cells and CTLs without feeder layers; our six year experience in India.
Dedeepiya V; Terunuma H; Manjunath S; Senthilkumar R; Thamaraikannan P; Srinivasan T; HelenReena C; Preethy S; Abraham S
J Stem Cells Regen Med; 2011; 7(2):95. PubMed ID: 24693182
[TBL] [Abstract][Full Text] [Related]
3. NK cell-based autologous immune enhancement therapy (AIET) for cancer.
Terunuma H; Deng X; Nishino N; Watanabe K
J Stem Cells Regen Med; 2013; 9(1):9-13. PubMed ID: 24693203
[TBL] [Abstract][Full Text] [Related]
4. Autologous immune enhancement therapy in recurrent ovarian cancer with metastases: a case report.
Manjunath SR; Ramanan G; Dedeepiya VD; Terunuma H; Deng X; Baskar S; Senthilkumar R; Thamaraikannan P; Srinivasan T; Preethy S; Abraham SJ
Case Rep Oncol; 2012 Jan; 5(1):114-8. PubMed ID: 22666198
[TBL] [Abstract][Full Text] [Related]
5. Autologous immune enhancement therapy: A case report of a stage IV colonic cancer.
Subramani B; Ratnavelu K; Pullai CR; Krishnan K; Sugadan SD; Deng X; Hiroshi T
Oncol Lett; 2013 May; 5(5):1611-1614. PubMed ID: 23761827
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence and novel therapies developed in Japan.
Iwasaki M
J Stem Cells Regen Med; 2012; 8(3):203-4. PubMed ID: 24693199
[TBL] [Abstract][Full Text] [Related]
7. Autologous immune enhancement therapy in a case of gall bladder cancer stage IV after surgical resection and chemotherapy yielding a stable non-progressive disease.
Bhamare S; Prabhakar P; Dharmadhikari A; Dedeepiya VD; Terunuma H; Senthilkumar R; Srinivasan T; Reena HC; Preethy S; Abraham SJ
J Cancer Res Ther; 2014; 10(3):752-4. PubMed ID: 25313776
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.
Goding SR; Yu S; Bailey LM; Lotze MT; Basse PH
Clin Immunol; 2017 Apr; 177():76-86. PubMed ID: 27377534
[TBL] [Abstract][Full Text] [Related]
9. Autologous immune enhancement therapy against an advanced epithelioid sarcoma: A case report.
Ratnavelu K; Subramani B; Pullai CR; Krishnan K; Sugadan SD; Rao MS; Veerakumarasivam A; Deng X; Hiroshi T
Oncol Lett; 2013 May; 5(5):1457-1460. PubMed ID: 23761810
[TBL] [Abstract][Full Text] [Related]
10.
Nhung HTM; Anh BV; Huyen TL; Hiep DT; Thao CT; Lam PN; Liem NT
Oncol Lett; 2018 Apr; 15(4):5730-5738. PubMed ID: 29552207
[TBL] [Abstract][Full Text] [Related]
11. In vitro induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes from patients with locally advanced breast cancer by tumor antigen-pulsed autologous dendritic cells.
Kass R; Agha J; Bellone S; Palmieri M; Canè S; Bignotti E; Henry-Tillman R; Hutchins L; Cannon MJ; Klimberg S; Santin AD
J Surg Res; 2003 Jun; 112(2):189-97. PubMed ID: 12888337
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer.
Ishikawa T; Okayama T; Sakamoto N; Ideno M; Oka K; Enoki T; Mineno J; Yoshida N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Konishi H; Kokura S; Uno K; Naito Y; Itoh Y
Int J Cancer; 2018 Jun; 142(12):2599-2609. PubMed ID: 29388200
[TBL] [Abstract][Full Text] [Related]
13. Cell Based Autologous Immune Enhancement Therapy (AIET) after Radiotherapy in a Locally Advanced Carcinoma of the Cervix.
Premkumar S; Dedeepiya VD; Terunuma H; Senthilkumar R; Srinivasan T; Reena HC; Preethy S; Abraham SJ
Case Rep Oncol Med; 2013; 2013():903094. PubMed ID: 23653878
[TBL] [Abstract][Full Text] [Related]
14. Natural killer-dendritic cell cross-talk in cancer immunotherapy.
Kalinski P; Mailliard RB; Giermasz A; Zeh HJ; Basse P; Bartlett DL; Kirkwood JM; Lotze MT; Herberman RB
Expert Opin Biol Ther; 2005 Oct; 5(10):1303-15. PubMed ID: 16197336
[TBL] [Abstract][Full Text] [Related]
15. Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cells.
Parajuli P; Mathupala S; Sloan AE
Neurosurgery; 2004 Nov; 55(5):1194-204. PubMed ID: 15509326
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A
Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers.
Lee SC; Shimasaki N; Lim JSJ; Wong A; Yadav K; Yong WP; Tan LK; Koh LP; Poon MLM; Tan SH; Ow SGW; Bharwani L; Yap YS; Foo MZQ; Coustan-Smith E; Sundar R; Tan HL; Chong WQ; Kumarakulasinghe NB; Lieow JLM; Koe PJX; Goh BC; Campana D
Clin Cancer Res; 2020 Sep; 26(17):4494-4502. PubMed ID: 32522887
[TBL] [Abstract][Full Text] [Related]
19. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma.
Hosseinzadeh F; Ai J; Ebrahimi-Barough S; Seyhoun I; Hajifathali A; Muhammadnejad S; Hosseinzadeh F; Shadnoush M; Dabiri Oskouei F; Verdi J
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3797-3803. PubMed ID: 31870124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
